Norgine B.V.

Jun 16, 2020

Norgine B.V. Senior Management Changes: Christopher Bath Appointed Chief Operating Officer

Feb 19, 2020

New Data Show Oral Ferric Maltol (FERACCRU®) May Be a Cost-effective Alternative to Intravenous (IV) Carboxymaltose With at Least as Great Benefits in the Quality of Life of Patients With Iron Deficiency Anaemia and Inflammatory Bowel Disease

Feb 12, 2020

Norgine B.V. Enters Into Exclusive Licence and Distribution Agreements for the Commercialisation of PLENVU® in a Number of Countries in Latin America, Southern Africa, Central and Eastern Europe

Sep 09, 2019

SpePharm AG Wins Case Against Eisai Inc. in United States District Court for District of Delaware

Jan 03, 2019

NORGINE B.V. and KOREA PHARMA CO., LTD. Enter Into Exclusive Licence Agreement for the Commercialisation of PLENVU® in the Republic of Korea

Jun 05, 2018

Salix And Its Partner Norgine Present New Data From PLENVU® (NER1006) Phase 3 Studies At Digestive Disease Week (DDW) 2018

Feb 09, 2018

Salix Provides Update on FDA Submission for PLENVU®*

Jun 05, 2017

Merus Labs International Inc. files Management Information Circular for Proposed Acquisition by Norgine B.V.